CVR number 35257632
Industry 869500

Vinderup Fysioterapi ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.3% 4.5% 4.7% 5.5% 4.6%  
Credit score (0-100)  48 45 45 40 46  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  2,318 2,412 2,174 2,246 2,487  
EBITDA  877 1,012 545 589 961  
EBIT  559 703 234 275 671  
Pre-tax profit (PTP)  442.2 572.2 152.9 113.5 504.1  
Net earnings  338.0 439.4 111.9 81.6 386.3  
Pre-tax profit without non-rec. items  442 572 153 114 504  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  1,824 1,735 1,709 1,614 1,544  
Shareholders equity total  492 932 643 475 611  
Interest-bearing liabilities  2,964 2,697 2,609 2,684 2,546  
Balance sheet total (assets)  4,290 4,445 4,226 4,056 3,945  
Net Debt  2,960 2,697 2,609 2,684 2,546  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,318 2,412 2,174 2,246 2,487  
Gross profit growth  29.8% 4.1% -9.9% 3.3% 10.7%  
Employees  3 4 4 5 4  
Employee growth %  50.0% 33.3% 0.0% 25.0% -20.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,290 4,445 4,226 4,056 3,945  
Balance sheet change%  33.0% 3.6% -4.9% -4.0% -2.7%  
Added value  876.6 1,012.2 545.4 585.7 961.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  1,032 -618 -557 -629 -580  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  24.1% 29.1% 10.8% 12.2% 27.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.1% 16.5% 5.9% 7.3% 17.4%  
ROI %  16.7% 18.8% 6.9% 8.8% 21.0%  
ROE %  104.6% 61.7% 14.2% 14.6% 71.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  11.5% 21.0% 15.2% 11.7% 15.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  337.7% 266.4% 478.3% 455.8% 264.9%  
Gearing %  602.3% 289.5% 405.4% 565.1% 416.4%  
Net interest  0 0 0 0 0  
Financing costs %  4.6% 5.2% 3.9% 7.1% 7.4%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.9 0.7 0.6 0.7 0.6  
Current Ratio  0.9 0.8 0.6 0.7 0.6  
Cash and cash equivalent  4.1 0.0 0.0 0.0 0.0  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -52.8 -418.1 -840.4 -605.6 -934.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  292 253 136 117 240  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  292 253 136 118 240  
EBIT / employee  186 176 59 55 168  
Net earnings / employee  113 110 28 16 97